1-4 of 4
Nancy A Brandenburg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reliability and Validity of the FACT-AN In Patients with Low or Int-1-Risk Myelodysplastic Syndromes with Deletion 5q.

Nancy A Brandenburg, PhD, Ren Yu, MA, Dennis A Revicki, PhD
Journal: Blood
Blood (2010) 116 (21): 3827.
https://doi.org/10.1182/blood.V116.21.3827.3827
Published: 2010
Journal Articles

Post-Approval Safety Study (PASS) of Lenalidomide Compared with Other Treatments In Patients with Relapsed or Refractory Multiple Myeloma: Evaluation of Peripheral Neuropathy In the First 1,011 Patients

Michel Delforge, Igor W. Blau, Miguel T. Hernandez, Roman Hajek, Luciano Masini, Henk Lokhorst, Giacinto La Verde, Laurence Sanhes, Javier De La Rubia, Janine Collins, Barbara Rosettani, Nancy A Brandenburg, Renato Zambello
Journal: Blood
Blood (2010) 116 (21): 1939.
https://doi.org/10.1182/blood.V116.21.1939.1939
Published: 2010
Journal Articles

Risk Factors for Venous Thromboembolism and the Use of Antithrombotic Prophylaxis in Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone Combination Regimens.

Nancy A Brandenburg, Tyler Knight, Zdravko Vassilev, Robert Knight
Journal: Blood
Blood (2009) 114 (22): 1385.
https://doi.org/10.1182/blood.V114.22.1385.1385
Published: 2009
Journal Articles

Evaluation of the Relationship Between Venous Thromboembolism Risk Factors and the Use of Antithrombotic Prophylaxis in Multiple Myeloma Patients Treated with Thalidomide and Dexamethasone Combination Regimens

Nancy A Brandenburg, PhD, Thomas F Goss, PharmD, Tyler Knight, MS, Xiao Xu, PhD, Robert D. Knight, MD
Journal: Blood
Blood (2008) 112 (11): 2369.
https://doi.org/10.1182/blood.V112.11.2369.2369
Published: 2008